{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T20:40:54Z","timestamp":1764535254217,"version":"3.46.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,30]]},"DOI":"10.7759\/cureus.98171","type":"journal-article","created":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T20:37:55Z","timestamp":1764535075000},"source":"Crossref","is-referenced-by-count":0,"title":["Systematic Inflammatory Response Syndrome (SIRS)-Like Reaction Following the Infusion of the Unregulated IV Supplement Hemobex"],"prefix":"10.7759","author":[{"given":"Jace A","family":"Leslie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Silberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilios","family":"Katsaitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans L","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al.. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021, 49:e1063-143. 10.1097\/CCM.0000000000005337","journal-title":"Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone RC","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, et al.. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992, 101:1644-55. 10.1378\/chest.101.6.1644","journal-title":"Chest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1952.62930060002012a","article-title":"Anaphylactic shock following intravenous administration of vitamin B complex","volume":"148","author":"Chitwood WR","year":"1952","unstructured":"Chitwood WR, Moore CD. Anaphylactic shock following intravenous administration of vitamin B complex. J Am Med Assoc. 1952, 148:461-2. 10.1001\/jama.1952.62930060002012a","journal-title":"J Am Med Assoc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-009648","article-title":"Anaphylactic shock and cardiac arrest caused by thiamine infusion","volume":"2013","author":"Juel J","year":"2013","unstructured":"Juel J, Pareek M, Langfrits CS, Jensen SE. Anaphylactic shock and cardiac arrest caused by thiamine infusion. BMJ Case Rep. 2013, 2013:14-6. 10.1136\/bcr-2013-009648","journal-title":"BMJ Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.32902\/2663-0338-2021-3-30-39","article-title":"The problem of hypersensitivity to vitamin preparations","volume":"4","author":"Zaikov S","year":"2021","unstructured":"Zaikov S, Gumeniuk G, Veselovsky L. The problem of hypersensitivity to vitamin preparations. Infus Chemother. 2021, 4:30-9. 10.32902\/2663-0338-2021-3-30-39","journal-title":"Infus Chemother"},{"key":"ref6","unstructured":"HEMOBEX Liver Extract + Vitamin B12 10ml Vial 3-Pack (Injections). (2025). Accessed. November 16, 2025: https:\/\/vitaminasdelsalvador.com\/product\/hemobex-vial-10ml-3pack-inyecciones-vitamina-b12\/."},{"key":"ref7","unstructured":"El Mundo newspaper. warning about counterfeit \u201cHemobex\u201d and how to identify it (Site in Spanish). (2025). Accessed: August 24, 2025: https:\/\/diario.elmundo.sv\/nacionales\/alertan-sobre-falsificacion-de-medicamento-hemobex-y-asi-puede-identificarlo."},{"key":"ref8","unstructured":"Soy502. Liver medication \u201cHemobex\u201d banned in Guatemala (Site in Spanish). (2025). Accessed. August 24, 2025: https:\/\/www.soy502.com\/articulo\/medicamento-higado-prohibido-guatemala-100931."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen A","year":"2018","unstructured":"Shimabukuro-Vornhagen A, G\u00f6del P, Subklewe M, et al.. Cytokine release syndrome. J Immunother Cancer. 2018, 6:56. 10.1186\/s40425-018-0343-9","journal-title":"J Immunother Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02014","article-title":"Interleukin-1 family cytokines: keystones in liver inflammatory diseases","volume":"10","author":"Barbier L","year":"2019","unstructured":"Barbier L, Ferhat M, Salam\u00e9 E, et al.. Interleukin-1 family cytokines: keystones in liver inflammatory diseases. Front Immunol. 2019, 10:2014. 10.3389\/fimmu.2019.02014","journal-title":"Front Immunol"},{"key":"ref11","article-title":"Type III Hypersensitivity Reaction","author":"Usman N","year":"2023","unstructured":"Usman N, Annamaraju P. Type III Hypersensitivity Reaction. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/cc12896","article-title":"Characteristics and outcomes of culture-negative versus culture-positive severe sepsis","volume":"17","author":"Phua J","year":"2013","unstructured":"Phua J, Ngerng W, See K, et al.. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013, 17:R202. 10.1186\/cc12896","journal-title":"Crit Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans L","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al.. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021, 47:1181-247. 10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190379","article-title":"Cytokine release syndrome and cancer immunotherapies - historical challenges and promising futures","volume":"14","author":"Shah D","year":"2023","unstructured":"Shah D, Soper B, Shopland L. Cytokine release syndrome and cancer immunotherapies - historical challenges and promising futures. Front Immunol. 2023, 14:1190379. 10.3389\/fimmu.2023.1190379","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422192-systematic-inflammatory-response-syndrome-sirs-like-reaction-following-the-infusion-of-the-unregulated-iv-supplement-hemobex","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T20:37:56Z","timestamp":1764535076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422192-systematic-inflammatory-response-syndrome-sirs-like-reaction-following-the-infusion-of-the-unregulated-iv-supplement-hemobex"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,30]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.98171","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,30]]}}}